Italy (IT)

Age- And weight-adapted dose of prasugrel versus standard dose of ticagrelor in patients with acute coronary syndromes: Results from a randomized trial (2020) Menichelli M, Neumann FJ, Ndrepepa G, Mayer K, Woehrle J, Bernlochner I, Richardt G, et al. Journal article Towards a common institutional trajectory? Individual complaints before UN treaty bodies during their ‘Booming’ years (2020) Cali B, Galand AS Journal article Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: A pilot study (2020) Schuett J, Bojorquez DIS, Avitabile E, Mata ESO, Milyukov G, Colditz J, Delogu LG, et al. Journal article Effects of school-based interventions on motivation towards physical activity in children and adolescents: A systematic review and meta-analysis (2020) Kelso A, Linder S, Reimers AK, Klug S, Alesi M, Scifo L, Borrego CC, et al. Journal article Birth rank as a determinant of academic achievement:results from a European survey of primary school children (2020) Arshad H, Husky MM, Gölitz D, Bitfoi A, Carta MG, Koc C, Lesinskiene S, et al. Journal article Overcoming key challenges in cancer immunotherapy with engineered T cells (2020) Arcangeli S, Mestermann K, Weber J, Bonini C, Casucci M, Hudecek M Journal article, Review article Feature projection-based unsupervised domain adaptation for acoustic scene classification (2020) Mezza AI, Habets E, Müller M, Sarti A Conference contribution In Vivo Validation of Spray-Dried Mesoporous Bioactive Glass Microspheres Acting as Prolonged Local Release Systems for BMP-2 to Support Bone Regeneration (2020) Berkmann JC, Herrera Martin AX, Pontremoli C, Zheng K, Bucher CH, Ellinghaus A, Boccaccini AR, et al. Journal article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution